Xvivo Perfusion AB (publ) (STO:XVIVO)

Xvivo Perfusion AB Revenue

Xvivo Perfusion AB had revenue of 238.99M SEK in the quarter ending June 30, 2026, with 34.04% growth. This brings the company's revenue in the last twelve months to 895.23M, up 8.79% year-over-year. In the year 2025, Xvivo Perfusion AB had annual revenue of 812.17M, down -1.25%.

• Revenue (ttm): 895.23M
• Revenue Growth: +8.79%
• P/S Ratio: 8.37
• Revenue / Employee: 4.54M
• Employees: 197
• Market Cap: 7.50B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	812.17M	-10.25M	-1.25%
Dec 31, 2024	822.42M	224.87M	37.63%
Dec 31, 2023	597.54M	182.25M	43.88%
Dec 31, 2022	415.29M	156.91M	60.73%
Dec 31, 2021	258.39M	78.53M	43.66%
Dec 31, 2020	179.86M	-40.98M	-18.55%
Dec 31, 2019	220.84M	32.97M	17.55%
Dec 31, 2018	187.87M	39.53M	26.65%
Dec 31, 2017	148.34M	10.17M	7.36%
Dec 31, 2016	138.18M	17.93M	14.91%
Dec 31, 2015	120.25M	35.54M	41.96%
Dec 31, 2014	84.70M	-	-

Data Source: Fiscal.ai Last updated: Jul 14, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 24, 2026

Data Sources Report a data error